Rival to EpiPen to be made available to many for free
January 23, 2017Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival
Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …
CEPI backed by Bill Gates raises funds to combat epidemics
January 23, 2017Medical Communications, Sales and Marketing Bill & Melinda Gates foundation, Bill Gates, CEPI
CEPI, the Coalition for Epidemic Preparedness Innovations, have launched the beginning of its fundraising initiative – with the aim of …
Leaflets offering gold coins for paediatricians appear at Bengaluru event
January 23, 2017Medical Communications, Sales and Marketing India, PEDICON
Pharmaceutical firms in India are not allowed to offer any kind of reimbursement for privileging certain treatment over others, this …
Artificial skin development has implications for clinical trials
January 23, 2017Medical Communications, Sales and Marketing Seoul National University Hospital, artificial skin, dermatology
Researchers from Seoul National University Hospital have announced that it has developed a microchip that has been designed to replicate …
BMS receives $625 million patent settlement boost from Merck
January 23, 2017Sales and Marketing BMS, MSD, Merck, keytruda, opdivo
Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be …
Company in 85,000% infant epilepsy drug price increase receives $100 million fine
January 23, 2017Sales and Marketing Mallinckrodt, Martin Skhreli
Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …
Asia-Pacific flu market to hit $1.71bn by 2022
January 20, 2017Business Services, Medical Communications APAC, GBI Research
According to new data from intelligence provider GBI Research, the flu vaccines market in the Asia-Pacific (APAC) region is set …
“Biggest leap in decades” for prostate cancer, 1 in 4 could avoid biopsies
January 20, 2017Medical Communications, Research and Development Biposy, prostate cancer
A new study has estimated that one in four men could avoid unnecessary invasive biopsies to detect prostate cancer – …
J&J’s Imbruvica scores fifth FDA lymphoma approval
January 20, 2017Medical Communications, Research and Development, Sales and Marketing FDA, Marginal Zone Lymphoma, imbruvica
Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …
Top Ten most popular articles on Pharmafile.com this week
January 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …
Pharmaceutical R&D tax credit regulatory legislation: The need for clarity
January 20, 2017Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile
Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …
Sanofi diabetes drug Sulinqua green-lighted in Europe
January 19, 2017Research and Development, Sales and Marketing Sanofi, Sulinqua
Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …
Boehringer steps into Humira race with US and EU biosimilar filings
January 19, 2017Sales and Marketing Boehringer Ingelheim, Humira, biosimilar
Boehringer Ingelheim has just stepped into the ring to battle it out for a slice of Humira’s revenue with accepted …
GSK snatches AZ Europe VP to replace exiting global head of pharma
January 19, 2017Business Services, Medical Communications, Sales and Marketing Abbas Hussain, Luke Miels
GlaxoSmithKline has announced that its global head of pharmaceuticals Abbas Hussain (pictured) is leaving the company; the vacated role will …
Allergan fined £15m over failure to disclose merger discussions
January 19, 2017Sales and Marketing Allergan, SEC
Allergan has been fined $15 million by the Security and Exchange Commission (SEC) after committing disclosure violations during merger talks …
Lilly brings migraine drug home with $960m acquisition
January 19, 2017Sales and Marketing CoLucid Pharmaceuticals, Eli Lilly
Eli Lilly has announced it is to shell out $960 million to snatch up CoLucid Pharmaceuticals and specifically its migraine …
Alcobra axes ADHD drug after Phase 3 failure
January 18, 2017Research and Development ADHD, Alcobra, metadoxine
Israeli-based firm Alcobra is to pull the plug on its experimental attention deficit hyperactivity disorder (ADHD) drug metadoxine after it …
Biogen shells out $1.25bn to protect best-selling MS drug
January 18, 2017Research and Development, Sales and Marketing Biogen, Forward Pharma, multiple sclerosis, tecfidera
Biogen has announced it is to pay $1.25 billion to Copenhagen-based biotech Forward Pharma in the latest development in a …
Researchers financed by pharma more likely to produce positive results, new report says
January 18, 2017Research and Development clinical trials
A new paper published in the British Medical Journal (BMJ) has called the integrity of certain clinical trials into question …
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
